Anaphylactic reaction after oral fluconazole.
作者信息
Neuhaus G, Pavic N, Pletscher M
出版信息
BMJ. 1991 Jun 1;302(6788):1341. doi: 10.1136/bmj.302.6788.1341-b.
Abstract
摘要
相似文献
1
Anaphylactic reaction after oral fluconazole.
BMJ. 1991 Jun 1;302(6788):1341. doi: 10.1136/bmj.302.6788.1341-b.
2
Oral fluconazole and vulvovaginal candidiasis: prevention is not always better than cure.
Prescrire Int. 2013 Sep;22(141):205.
3
Oral fluconazole for vaginal candidiasis.
Med Lett Drugs Ther. 1994 Sep 16;36(931):81-2.
4
Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
N Engl J Med. 2004 Aug 26;351(9):876-83. doi: 10.1056/NEJMoa033114.
5
Management of chronic vulvovaginal candidiasis: a long term retrospective study.
Australas J Dermatol. 2017 Nov;58(4):e188-e192. doi: 10.1111/ajd.12497. Epub 2016 Jun 2.
6
[Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)].
Akush Ginekol (Sofiia). 2005;44 Suppl 2:17-20.
7
8
[Fluconazole administration during pregnancy].
Harefuah. 1998 Sep;135(5-6):243-6.
9
Fluconazole administration leading to anaphylactic shock in a preterm newborn.
Neonatal Netw. 2014 Mar-Apr;33(2):83-5. doi: 10.1891/0730-0832.33.2.83.
10
[Toxic epidermal necrolysis].
Hautarzt. 2006 Apr;57(4):322-4. doi: 10.1007/s00105-006-1111-1.
引用本文的文献
1
Bullous erythema multiforme secondary to fluconazole intake: A unique case report managed with photobiomodulation therapy.
Natl J Maxillofac Surg. 2024 Jan-Apr;15(1):151-153. doi: 10.4103/njms.njms_128_22. Epub 2024 Mar 19.
2
Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.
ChemMedChem. 2015 Oct;10(10):1672-86. doi: 10.1002/cmdc.201500271. Epub 2015 Aug 12.
3
Lack of allergic cross-reactivity between fluconazole and voriconazole.
Antimicrob Agents Chemother. 2009 Apr;53(4):1715-6. doi: 10.1128/AAC.01500-08. Epub 2009 Jan 21.
4
Systemic vs. topical therapy for the treatment of Vulvovaginal Candidiasis.
Infect Dis Obstet Gynecol. 1994;1(4):202-8. doi: 10.1155/S1064744994000098.
5
Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis.
Pharmacoeconomics. 1996 Jun;9(6):497-505. doi: 10.2165/00019053-199609060-00004.
6
Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis.
Drugs. 1995 Jun;49(6):984-1006. doi: 10.2165/00003495-199549060-00009.
7
Adverse drug reactions to systemic antifungals. Prevention and management.
Drug Saf. 1992 Sep-Oct;7(5):323-63. doi: 10.2165/00002018-199207050-00003.
本文引用的文献
1
Anaphylactic reactions to ketoconazole.
Br Med J (Clin Res Ed). 1983 Dec 3;287(6406):1673. doi: 10.1136/bmj.287.6406.1673.
Zotero 插件